Sign in

Private company

DermTech, Inc.

American medical laboratories services company, incorporated in Delaware1

In its 2024 annual report the company says: “We are a molecular diagnostic company developing and marketing novel non-invasive genomics tests to aid in the diagnosis and management of melanoma. Our scalable genomics assays have been designed to work with our adhesive patch, the DermTech Smart Sticker TM, which is used to non-invasively collect skin tissue samples for analysis. We are addressing unmet needs in the clinical evaluation pathway of pigmented skin lesions, such as moles or dark colored skin spots.”3 It is headquartered in San Diego, California.1

Last updated Oct 21, 2026.

Overview

  • IndustryServices-Medical Laboratories1
  • HeadquartersSan Diego, California1
  • Incorporated inDE2
  • Business address12340 El Camino Real, San Diego, Ca 921302
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Unless specifically noted otherwise, as used throughout this Business section, “we,” “our,” “us,” or the “Company” refers to the business, operations and financial results of DermTech Operations prior to, and the Company and its subsidiaries subsequent to, the completion of the Business Combination as the context requires. “Constellation” refers to the Company prior to the completion of the Business Combination.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

1.8%Gross margin4
-678.2%Operating margin4
-659.6%Net margin4
5.4%Revenue growth, 20234
-176.5%Return on equity4
-$77.9MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue50¢$15.0M
  • Research and development50¢$15.2M

Out of $15.3M in revenue.4 The company lost money this year.

Financial statements

Revenue5674$15.3M in 2023+526% since 2018
0$5.0M$10.0M$15.0M$20.0M2018: $2.4M$2.4M20182019: $3.4M$3.4M2019+38%2020: $5.9M$5.9M2020+75%2021: $11.8M$11.8M2021+101%2022: $14.5M$14.5M2022+23%2023: $15.3M$15.3M2023+5%
Gross profit5674$276.0K in 2023
-$500.0K0$500.0K$1.0M$1.5M2018: -$185.0K-$185.0K20182019: $60.0K$60.0K20192020: -$96.0K-$96.0K20202021: $1.3M$1.3M20212022: $647.0K$647.0K2022−49%2023: $276.0K$276.0K2023−57%
Operating income85674-$103.7M in 2023+172898233% since 2017
-$150.0M-$100.0M-$50.0M02017: -$60-$6020172018: -$8.6M-$8.6M2018+14266567%2019: -$17.6M-$17.6M2019+106%2020: -$35.3M-$35.3M2020+100%2021: -$77.4M-$77.4M2021+119%2022: -$118.2M-$118.2M2022+53%2023: -$103.7M-$103.7M2023−12%
Net income85674-$100.9M in 2023+168146567% since 2017
-$150.0M-$100.0M-$50.0M02017: -$60-$6020172018: -$10.0M-$10.0M2018+16673233%2019: -$20.1M-$20.1M2019+101%2020: -$36.5M-$36.5M2020+81%2021: -$78.3M-$78.3M2021+115%2022: -$116.7M-$116.7M2022+49%2023: -$100.9M-$100.9M2023−14%
Fiscal year2017201820192020202120222023
Revenue$2.4M5$3.4M6$5.9M6$11.8M7$14.5M4$15.3M4
Cost of revenue$2.6M5$3.3M6$6.0M6$10.6M7$13.9M4$15.0M4
Gross profit-$185.0K5$60.0K6-$96.0K6$1.3M7$647.0K4$276.0K4
Research and development$2.1M5$2.5M6$5.3M6$16.3M7$24.1M4$15.2M4
Operating expenses$78.7M7$118.8M4$104.0M4
Operating income-$608-$8.6M5-$17.6M6-$35.3M6-$77.4M7-$118.2M4-$103.7M4
Net income-$608-$10.0M5-$20.1M6-$36.5M6-$78.3M7-$116.7M4-$100.9M4
Earnings per share-$2.717-$3.884-$3.094
Earnings per share (diluted)-$2.717-$3.884-$3.094
Shares (weighted, basic)28.9M shares730.0M shares432.6M shares4
Shares (weighted, diluted)28.9M shares730.0M shares432.6M shares4

Compare DermTech, Inc. with another company

Corporate structure

DermTech, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of DermTech, Inc.

  • VAN HERK INVESTMENTS B.V. Filed SC 13G on DermTech, Inc., latest Apr 26, 2024 (3 filings since Jun 16, 2023)
  • RTW INVESTMENTS, LP Filed SC 13D/A on DermTech, Inc., latest Dec 12, 2023 (2 filings since Nov 8, 2022)
  • Casdin Capital, LLC Filed SC 13G/A on DermTech, Inc., latest Feb 14, 2023 (2 filings since Feb 14, 2022)
  • State Street Corporation Filed SC 13G/A on DermTech, Inc., latest Feb 3, 2023 (4 filings since Feb 10, 2022)
  • BlackRock Filed SC 13G on DermTech, Inc., latest Jul 8, 2022 (2 filings since Feb 4, 2022)
  • DermTech, Inc. San Diego, California

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What DermTech, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Machinery and equipment$6.1M4 Dec 31, 2023$6.2M4 Dec 31, 2022−2.4%
Furniture and fixtures$1.2M4 Dec 31, 2023$913.0K4 Dec 31, 2022+36.7%
Leasehold improvements$604.0K4 Dec 31, 2023$1.3M4 Dec 31, 2022−55.1%
Property and equipment, before depreciation$8.8M4 Dec 31, 2023$9.4M4 Dec 31, 2022−6.4%
Accumulated depreciation$3.8M4 Dec 31, 2023$3.0M4 Dec 31, 2022+26.3%
Property and equipment, net$5.0M4 Dec 31, 2023$6.4M4 Dec 31, 2022−21.8%
Operating-lease assets (leased space)$51.7M4 Dec 31, 2023$56.0M4 Dec 31, 2022−7.7%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$36.7M4 Dec 31, 2023$77.8M4 Dec 31, 2022−52.7%
Marketable securities, current$19.1M4 Dec 31, 2023$48.4M4 Dec 31, 2022−60.5%
Debt securities available for sale$19.1M4 Dec 31, 2023$48.4M4 Dec 31, 2022−60.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$1.0M4 Dec 31, 2023$1.8M4 Dec 31, 2022−42.9%

Leadership

Who has led DermTech, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Rajiv Shukla2017
  2. John Dobak2019–2023
  3. Bret Christensen2023

Chair

  1. Rajiv Shukla2017

Chief financial officer

  1. Craig Pollak2017
  2. Steven J. Kemper2019
  3. Kevin M. Sun2019–2024

Chief operating officer

  1. Claudia Ibarra2020–2023
20202025
Board members and other officers (20)

Former names

  • Constellation Alpha Capital Corp.Sep 24, 2015 to Sep 5, 20192

Timeline

  1. Jun 20, 20248-K Listing notice or transfer39
  2. Jun 18, 20248-K Bankruptcy or receivership; Exit or restructuring costs; Executive or director change40
  3. May 17, 20248-K Debt or obligation accelerated; Other events41
  4. May 14, 20248-K Results of operations42
  5. May 10, 20248-K Debt or obligation accelerated43
  6. Apr 18, 20248-K Exit or restructuring costs; Other events44
  7. Apr 16, 20248-K Listing notice or transfer45
  8. Feb 29, 20248-K Results of operations46
  9. Jan 31, 20248-K Exit or restructuring costs; Executive or director change; Other events47
  10. Nov 2, 20238-K Results of operations48
  11. Sep 11, 20238-K Executive or director change; Other events49
  12. Aug 3, 20238-K Results of operations50
  13. May 10, 2023New chief executive Bret Christensen becomes CEO14
  14. Sep 9, 2019New chief executive John Dobak becomes CEO15
  15. Jun 19, 2017New chief executive Rajiv Shukla becomes CEO16

Calendar

When it reported results

  1. May 14, 2024Reported quarterly or annual results42
  2. Feb 29, 2024Reported quarterly or annual results46
  3. Nov 2, 2023Reported quarterly or annual results48
  4. Aug 3, 2023Reported quarterly or annual results50
  5. May 4, 2023Reported quarterly or annual results51
  6. Mar 2, 2023Reported quarterly or annual results52
  7. Aug 8, 2022Reported quarterly or annual results53
  8. May 3, 2022Reported quarterly or annual results54

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

166 filings to the SEC since October 2021: 4 annual reports, 8 quarterly reports, 30 major events, 90 insider forms, 13 large holders, 21 other. The latest 20:

  1. Apr 2, 202615-12G EDGAR
  2. Jun 20, 20248-K EDGAR
  3. Jun 18, 20248-K EDGAR
  4. Jun 12, 20244 EDGAR
  5. Jun 7, 20244 EDGAR
  6. Jun 7, 20244 EDGAR
  7. May 17, 20248-K EDGAR
  8. May 15, 202410-Q EDGAR
  9. May 14, 20248-K EDGAR
  10. May 10, 20248-K EDGAR
  11. Apr 26, 202410-K/A EDGAR
  12. Apr 26, 2024SC 13G EDGAR
  13. Apr 18, 20248-K EDGAR
  14. Apr 16, 20248-K EDGAR
  15. Mar 12, 20244 EDGAR
  16. Mar 12, 20244/A EDGAR
  17. Mar 7, 20244 EDGAR
  18. Mar 7, 20244 EDGAR
  19. Mar 7, 2024S-8 EDGAR
  20. Feb 29, 202410-K EDGAR

The 166 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

73 open-market trades by officers, directors and large owners since October 2021: 2 buys and 71 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Dec 11, 2023Sun Kevin MChief Financial OfficerSale447$1.45$648Form 4
Dec 11, 2023Ibarra ClaudiaChief Operating OfficerSale331$1.45$480Form 4
Dec 8, 2023Ibarra ClaudiaChief Operating OfficerSale2,607$1.41$3.7KForm 4
Dec 7, 2023Sun Kevin MChief Financial OfficerSale4,979$1.53$7.6KForm 4
Dec 7, 2023Ibarra ClaudiaChief Operating OfficerSale3,911$1.53$6.0KForm 4
Dec 7, 2023Akhavan RaminGeneral CounselSale3,768$1.53$5.8KForm 4
Sep 11, 2023Sun Kevin MChief Financial OfficerSale436$1.89$824Form 4
Sep 11, 2023Ibarra ClaudiaChief Operating OfficerSale322$1.89$609Form 4
Sep 8, 2023Sun Kevin MChief Financial OfficerSale9,180$1.93$17.7KForm 4
Sep 8, 2023Ibarra ClaudiaChief Operating OfficerSale7,378$1.93$14.2KForm 4
Sep 8, 2023Akhavan RaminGeneral CounselSale4,531$1.93$8.7KForm 4
Jun 12, 2023Wood Todd MichaelChief Commercial OfficerSale350$2.85$998Form 4
Jun 12, 2023Sun Kevin MChief Financial OfficerSale437$2.85$1.2KForm 4
Jun 12, 2023Ibarra ClaudiaChief Operating OfficerSale322$2.85$918Form 4
Jun 8, 2023Sun Kevin MChief Financial OfficerSale2,828$2.61$7.4KForm 4
Jun 8, 2023Ibarra ClaudiaChief Operating OfficerSale2,371$2.61$6.2KForm 4
Jun 7, 2023Wood Todd MichaelChief Commercial OfficerSale4,992$2.53$12.6KForm 4
Jun 7, 2023Sun Kevin MChief Financial OfficerSale4,988$2.53$12.6KForm 4
Jun 7, 2023Ibarra ClaudiaChief Operating OfficerSale3,916$2.53$9.9KForm 4
Jun 7, 2023Akhavan RaminGeneral CounselSale3,776$2.53$9.6KForm 4

All 73 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How DermTech, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARDermTech, Inc.1
  • CIK0001651944
  • Employer ID (EIN)84-28708491
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)8071 Services-Medical Laboratories1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address12340 El Camino Real, San Diego, CA 921301
  • Phone858-450-42221
  • Shares outstanding34,962,994 as of May 8, 202411
  • Public float$85.2M as of Jun 30, 202360
  • On EDGAR sinceSep 24, 20151
  • Filings497 in all: 4 (193), 8-K (70), 3 (32), 424B3 (22), 10-Q (21), CORRESP (17), UPLOAD (15), SC 13G/A (13)1
    All 45 form types

    SC 13G (12), EFFECT (9), S-8 (9), 10-K (7), DEFA14A (6), DEF 14A (5), S-3 (5), SC 13D/A (5), 424B5 (4), SC 13D (4), 25-NSE (3), 4/A (3), PRE 14A (3), S-1 (3), S-1/A (3), S-4/A (3), 144 (2), 3/A (2), 425 (2), 8-K/A (2), D (2), DRS/A (2), POS AM (2), PRER14A (2), RW (2), 10-K/A (1), 15-12G (1), 424B4 (1), 8-A12B (1), ARS (1), CERTNAS (1), DRS (1), DRSLTR (1), NT 10-K (1), NT 10-Q (1), PREM14A (1), S-4 (1)

  • Latest filingsAnnual report (10-K) Feb 29, 2024
    Quarterly report (10-Q) May 15, 2024
    Proxy statement (DEF 14A) Apr 11, 2023
    Latest 8-K (8-K) Jun 20, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60